Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

38.68 +0.78 (+2.05%)

Streaming Delayed Price Updated: 11:56 AM EDT, Aug 6, 2026 Add to My Watchlist

Price and Volume

Volume	77,090
Open	37.91
Bid (Size)	38.52 (100)
Ask (Size)	38.71 (1,000)
Prev. Close	37.90
Today's Range	37.65 - 38.92
52wk Range	12.56 - 38.90
Shares Outstanding	54,902,942
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference

July 30, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

July 29, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Performance

YTD	+188.9%	+188.9%
1 Month	+32.9%	+32.9%
3 Month	+101.3%	+101.3%
6 Month	+156.0%	+156.0%
1 Year	+153.6%	+153.6%

More News

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

July 21, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 15, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

June 10, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

May 27, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors. ↗

May 17, 2026

Via The Motley Fool

ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million

May 12, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Q1 Earnings Call Highlights ↗

May 08, 2026

Via MarketBeat

PLSE Q1 2026 Earnings Transcript ↗

May 08, 2026

Via The Motley Fool

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

May 08, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

PLSE Q4 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

May 04, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026

April 25, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting

April 20, 2026

From Pulse Biosciences

Via Business Wire

Pulse Biosciences to Host Analyst Event on April 25, 2026

April 17, 2026

From Pulse Biosciences

Via Business Wire

Pulse Biosciences Strengthens Executive Leadership Team

April 09, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

April 07, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference

April 02, 2026

From Pulse Biosciences, Inc

Via Business Wire

Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data

March 17, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

March 12, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation

March 09, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

March 05, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting

March 04, 2026

From Pulse Biosciences, Inc.

Via Business Wire

Frequently Asked Questions

Is Pulse Biosciences, Inc - Common Stock publicly traded?

Yes, Pulse Biosciences, Inc - Common Stock is publicly traded.

What exchange does Pulse Biosciences, Inc - Common Stock trade on?

Pulse Biosciences, Inc - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Pulse Biosciences, Inc - Common Stock?

The ticker symbol for Pulse Biosciences, Inc - Common Stock is PLSE on the Nasdaq Stock Market

What is the current price of Pulse Biosciences, Inc - Common Stock?

The current price of Pulse Biosciences, Inc - Common Stock is 38.68

When was Pulse Biosciences, Inc - Common Stock last traded?

The last trade of Pulse Biosciences, Inc - Common Stock was at 08/06/26 11:56 AM ET

What is the market capitalization of Pulse Biosciences, Inc - Common Stock?

The market capitalization of Pulse Biosciences, Inc - Common Stock is 2.12B

How many shares of Pulse Biosciences, Inc - Common Stock are outstanding?

Pulse Biosciences, Inc - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.